glp-1 prescriptions q1 2025 Impact: How GLP-1s Are Changing the Diabetes Treatment Paradigm Monitoring Report: GLP-1 RA Prescribing
Description
The SURPASS clinical trial program demonstrated superior A1C reductions compared to semaglutide, with many patients achieving normal blood glucose levels
Park HC, Lee YK, Cho A, et al
Fernando Ovalle Jr., a double board-certified plastic surgeon and obesity medicine specialist, explains that some nutrients and supplements can modestly influence appetite, blood sugar, or satiety pathways, but they act much more subtly than GLP-1 medications
She earned her J.D
den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, et al
They shape patient experience, influence adherence, and alter how both clinicians and pharmacies approach therapy
